J Endocr Surg.  2019 Dec;19(4):154-156. 10.16956/jes.2019.19.4.154.

Efficacy of Percutaneous Thermal Ablation of Papillary Thyroid Carcinoma

Affiliations
  • 1Division for Endocrine and Minimally Invasive Surgery, Department of Human Pathology in Adulthood and Childhood “G. Barresi”, University Hospital G. Martino, University of Messina, Messina, Italy. ettore_caruso@hotmail.it

Abstract

Percutaneous thermoablation (PTA) has become an increasingly used option in the interventional treatment of symptomatic, cytologic and sonographic benign solid thyroid gland disease. Currently, there is no high-level evidence of treatment for differentiated thyroid cancer by means of PTA. Surgery is a standard treatment for primary and also for recurrent thyroid cancer, followed by radioactive iodine and thyroid hormone therapy. PTA, however, can be used in patients at high-risk and in patients who refuse to undergo repeated surgery. The Task Force Committee of the Korean Society of Thyroid Radiology has developed recommendations for the optimal use of PTA for thyroid nodules. However, there are still several questions on safe distance to the laryngeal nerves, no data on duration of PTA application around the nerves, no intra-procedure assessment of laryngeal nerves function and position. Future experimental studies are required.

Keyword

Papillary thyroid carcinoma; Thyroid

MeSH Terms

Advisory Committees
Humans
Iodine
Laryngeal Nerves
Thyroid Gland*
Thyroid Neoplasms*
Thyroid Nodule
Ultrasonography
Iodine

Reference

1. Trimboli P, Castellana M, Sconfienza LM, Virili C, Pescatori LC, Cesareo R, et al. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine. 2019.
Article
2. Ben Hamou A, Ghanassia E, Espiard S, Abi Rached H, Jannin A, Correas JM, et al. Safety and efficacy of thermal ablation (radiofrequency and laser): should we treat all types of thyroid nodules? . Int J Hyperthermia. 2019; 36:666–676.
3. Sim JS, Baek JH. Long-term outcomes following thermal ablation of benign thyroid nodules as an alternative to surgery: the importance of controlling regrowth. Endocrinol Metab (Seoul). 2019; 34:117–123.
Article
4. Trimboli P, Pelloni F, Bini F, Marinozzi F, Giovanella L. High-intensity focused ultrasound (HIFU) for benign thyroid nodules: 2-year follow-up results. . Endocrine. 2019; 65:312–317.
Article
5. Ma B, Wei W, Xu W, Wang Y, Guan H, Fan J, et al. Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: a retrospective case review and literature review. Thyroid. 2018; 28:1134–1142. – .
Article
6. De Bernardi IC, Floridi C, Muollo A, Giacchero R, Dionigi GL, Reginelli A, et al. Vascular and interventional radiology radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: literature review. Radiol Med (Torino). 2014; 119:512–520.
Article
7. Morelli F, Ierardi AM, Pompili G, Sacrini A, Biondetti P, Angileri SA, et al. Cooled tip radiofrequency ablation of benign thyroid nodules: preliminary experience with two different devices. Gland Surg. 2018; 7:67–79.
Article
8. Duka E, De Marchi G, Giacchero R, Mangano A, Piantanida E, Tanda ML, et al. Image-guided thyroid nodule ablation: technical notes and critical appraisal. Surg Technol Int. 2014; 25:103–109.
9. Lee GM, You JY, Kim HY, Chai YJ, Kim HK, Dionigi G, et al. Successful radiofrequency ablation strategies for benign thyroid nodules. Endocrine. 2019; 64:316–321.
Article
10. Dralle H. Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma. Chirurg. 2019; 90:936.
11. Na DG, Lee JH, Jung SL, Kim JH, Sung JY, Shin JH, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012; 13:117–125.
Article
Full Text Links
  • JES
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr